Abstract:AIM: To investigate synergism of inhibition of telomerase activity and proliferation of human colon cancer cells by combination of telomerase antisense oligonucleotides (ASODNs) simultaneously targeting human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT) in vitro. METHODS: ASODN of hTR and ASODN of hTERT were transfected into human colon cancer SW480 cells by liposomal transfection reagents. Telomerase activity of SW480 cells was examined using telomeric repeat amplification protocol (TRAP)-enzyme-linked immunosorbent assay (PCR-ELISA). Proliferation activity of SW480 cells was tested by methyl thiazolyl tetrazolium assay. Apoptosis and cell cycle were analyzed by flow cytometry. RESULTS: The telomerase activity and cell survival rate in SW480 cells transfected with 0.2 mu mol/L of ASODN of hTR or ASODN of hTERT for 24-72 h were significantly decreased in a time-dependent manner compared with those after treatment with sense oligonucleotides and untreated (telomerase activity: 24 h, 73%, 74% vs 99%, 98%; 48 h, 61%, 55% vs 98%, 99%; 72 h, 41%, 37% vs 99%, 97%; P<0.01; cell survival rate: 24 h, 88%, 86% vs 94%, 98%; 48 h, 49%, 47% vs 94%, 97%; 72 h, 44%, 42% vs 92%, 96%; P<0.01). Moreover, the telomerase activity and the cell survival rate in SW480 cells treated by the combination of telomerase anti-hTR and anti-hTERT were more significantly suppressed than single anti-hTR or anti-hTERT (telomerase activity: 24 h, 59% vs 73%, 74%; 48 h, 43% vs 61%, 55%; 72 h, 18% vs 41%, 37%; P<0.01; cell survival rate: 24 h, 64% vs 88%, 86%; 48 h, 37% vs 49%, 47%; 72 h, 25% vs 44%, 42%; P<0.01). Meanwhile, the apoptosis rates in the combination group were markedly increased compared with those in the single group (24 h, 18.0% vs 7.2%, 7.4%; 48 h, 23.0% vs 13.0%, 14.0%; 72 h, 28.6% vs 13.2%, 13.75; P<0.01). Cells in combination group were arrested at G(0)/G(1) phase. CONCLUSION: Telomerase anti-hRT and anti-hTERT suppress telomerase activity, and inhibit growth of human colon cancer cells probably via induction of apoptosis and retardation of cell cycle. Additionally, combined use of telomerase ASODNs targeting both hTR and hTERT yields synergistic action selective for human colon cancer. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.

Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line

Interferon-α in Combination with Homoharringtonine Induces K562 Cell Apoptosis Through Down-Regulating Human Telomerase Reverse Transcriptase Expression and Telomerase Activity

Synergistic Down-Regulation of Telomerase by All-Trans Retinoic Acid and Antisense Oligonucleotide in Oral Squamous Cell Carcinoma Cell Line (Tca8113)

Telomerase Activity and Cell Apoptosis in Colon Cancer Cell by Human Telomerase Reverse Transcriptase Gene Antisense Oligodeoxynucleotide.

Antisense Oligonucleotides and All-Trans Retinoic Acid Have a Synergistic Anti-Tumor Effect on Oral Squamous Cell Carcinoma

Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy

Antitumor Efficacy of Human Telomerase Reverse Transcriptase Gene Antisense Oligonucleotide in Pancreatic Cancer Cells.

[Effect of Human Telomerase Reverse Transcriptase Gene Antisense Oligonucleotide on Sensitivity of Gemcitabine in Pancreatic Cancer Cell].

Stable Expression of Antisense Htr Inhibits in Vitro Pancreatic Cancer Cell Growth.

Can Inhibition of Telomerase Increase Pancreatic Cancer Cell's Susceptibility to Chemotherapeutic Reagents?

Effect of Antisense Oligodeoxynucleotide of Telomerase RNA on Telomerase Activity and Cell Apoptosis in Human Colon Cancer

The antitumor effect and mechanism of antisense oligonucleotide against hTR with all-trans retinoic acid on oral squamous cell carcinoma

Antisense oligodeoxynucleotide against human telomerase reverse transcriptase inhibits the proliferation of Eca-109 esophageal carcinoma cells

Effect of telomerase antisense oligodeoxynucleotide on telomerase activity and cell growth in human breast cancer cell

[Inhibition of Telomerase Activity and Induction of Apoptosis in Lung Cancer Cell by Human Telomerase Reverse Transcriptase Gene Antisense Oligodeoxynucleotide].

[Inhibition of Htert Antisense Oligodeoxynucleotide on Proliferation and Telomerase Activity in HL-60 Cells].

In vitro and in vivo tumor suppressive activity induced by human telomerase transcriptase-targeting antisense oligonucleotides mediated by cationic liposomes.

Antisense Htert Inhibits Thyroid Cancer Cell Growth.

Inhibitory Effects of Antisense Phosphorothioate Oligodeoxynucleotides on Pancreatic Cancer Cell Bxpc-3 Telomerase Activity and Cell Growth in Vitro

Human Telomerase Reverse Transcriptase Gene Antisense Oligonucleotide Increases the Sensitivity of Pancreatic Cancer Cells to Gemcitabine In Vitro

Antisense Oligonucleotide Targeting at the Initiator of Htert Arrests Growth of Hepatoma Cells.